Type to search

Bioscience and pharmaceutical Economic Development Insider Only New Castle County News

Incyte sees growing opportunity in dermatology

Avatar photo
Share

WILMINGTON – When researchers at biopharmaceutical firm Incyte discovered that their blockbuster small-molecule cancer drug could also treat dermatological conditions like vitiligo and eczema, it marked a sea change in the company’s course. Incyte secured the first U.S. Food & Drug Administration approval for a vitiligo treatment, Opzelura, last summer. Then in November, it doubled

Want to Read More?

Paid DBT subscribers get unlimited access to all Insider content and much more. Learn more in our Insider FAQ.

Become an Insider Now

Already an Insider? Log In.

Tags:

You Might also Like

Leave a Comment

Your email address will not be published. Required fields are marked *

Premier Digital Partners

© 2023 Delaware Business Times

Flash Sale! Subscribe to Delaware Business Times and save 50%.

Limited time offer. New subscribers only.

Limited time offer. New subscribers only.

SUMMER FLASH SALE!

Subscribe to Delaware Business Times and save 50%